This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Mattano Jr LA, Sather HN, Trigg ME, Nachman JB . Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children's Cancer Group. J Clin Oncol 2000; 18: 3262–3272.
Assouline-Dayan Y, Chang C, Greenspan A, Shoenfeld Y, Gershwin ME . Pathogenesis and natural history of osteonecrosis. Semin Arthritis Rheum 2002; 32: 94–124.
Berger CE, Kluger R, Urban M, Kowalski J, Haas OA, Engel A . Elevated levels of lipoprotein(a) in familial bone marrow edema syndrome of the hip. Clin Orthop 2000; 377: 126–131.
Utermann G . Lipoprotein(a). In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds). The Metabolic & Molecular Bases of Inherited Disease, 8th edn. McGraw-Hill: New York, 2001, pp 2753–2787.
Kraft HG, Kochl S, Menzel HJ, Sandholzer C, Utermann G . The apolipoprotein (a) gene: a transcribed hypervariable locus controlling plasma lipoprotein (a) concentration. Hum Genet 1992; 90: 220–230.
Glueck CJ, Crawford A, Roy D, Freiberg R, Glueck H, Stroop D . Association of antithrombotic factor deficiencies and hypofibrinolysis with Legg-Perthes disease. J Bone Joint Surg Am 1996; 78: 3–13.
Posan E, Szepesi K, Gaspar L, Csernatony Z, Harsfalvi J, Ajzner E et al. Thrombotic and fibrinolytic alterations in the aseptic necrosis of femoral head. Blood Coagul Fibrinolysis 2003; 14: 243–248.
Motomura G, Yamamoto T, Miyanishi K, Jingushi S, Iwamoto Y . Combined effects of an anticoagulant and a lipid-lowering agent on the prevention of steroid-induced osteonecrosis in rabbits. Arthritis Rheum 2004; 50: 3387–3391.
Relling MV, Yang W, Das S, Cook EH, Rosner GL, Neel M et al. Pharmacogenetic risk factors for osteonecrosis of the hip among children with leukemia. J Clin Oncol 2004; 22: 3930–3936.
Acknowledgements
The authors thank Professor Dr G Utermann for providing the apo(a) probe and Dr B Leeuw from the UMC Groningen, Department of Pediatric Oncology for providing us data from one patient.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
van Beek, R., Bezemer, D., Meijerink, J. et al. Repeats in the kringle IV encoding domains in the Apo(a) gene and serum lipoprotein(a) level do not contribute to the risk for avascular necrosis of the bone (AVN) in pediatric acute lymphoblastic leukemia. Leukemia 20, 879–880 (2006). https://doi.org/10.1038/sj.leu.2404161
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2404161
This article is cited by
-
Genetic Biomarkers to Identify the Risk of Osteonecrosis in Children with Acute Lymphoblastic Leukemia
Molecular Diagnosis & Therapy (2016)